Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Journal of the American Academy of Dermatology (JAAD)
Published September 25, 2026
Clinical characteristics and risk factors for a distinct pustular psoriasis flare after withdrawa...
September 26, 2026
Medspoke
Medspoke
British Journal of Dermatology
Published September 26, 2026
00:00
--:--
Upadacitinib for Palmoplantar Pustulosis: An Open-label, Assessor-blinded Feasibility Study Using...
September 26, 2026
Share
Upadacitinib for Palmoplantar Pustulosis: An Open-label, Assessor-blinded Feasibility Study Using Historic Control Data (JAKPPPOT).
https://www.medspoke.co/channel_journal?id=875&tap_id=14473
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
British Journal of Dermatology
Published September 26, 2026
Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phas...
September 26, 2026
Why are you reporting this TALK?
